6525--Intent to Sole Source: TheraSphere Y-90 Glass Microspheres

SOL #: 36C24726Q0265Special NoticeSole Source

Overview

Buyer

Veterans Affairs
Veterans Affairs, Department Of
247-NETWORK CONTRACT OFFICE 7 (36C247)
AUGUSTA, GA, 30904, United States

Place of Performance

Place of performance not available

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

X Ray Equipment And Supplies: Medical, Dental, Veterinary (6525)

Set Aside

No set aside specified

Timeline

1
Posted
Feb 5, 2026
2
Action Date
Feb 20, 2026, 3:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Veterans Affairs (VA), specifically the Network Contracting Office 7, intends to award a sole-source, firm-fixed-price contract to Boston Scientific Corporation for TheraSphere Y-90 Glass Microspheres. This requirement is for the Ralph H. Johnson Veteran Affairs Medical Center in Charleston, SC, to provide targeted radiation therapy for liver cancers. Interested parties believing they can meet this requirement must submit a capability statement by February 20, 2026, at 10:00 AM ET.

Scope of Work

This opportunity is for the ongoing provision of TheraSphere Y-90 Glass Microspheres. These microscopic glass beads contain radioactive Yttrium-90 (Y-90) and are used for targeted radiation therapy. The therapy delivers high-dose beta radiation directly to liver tumors via the hepatic artery, aiming to kill cancer cells while sparing healthy tissue.

Contract & Timeline

  • Type: Intent to Sole Source (Firm-Fixed-Price)
  • Designated Source: Boston Scientific Corporation
  • Period of Performance: May 1, 2025, through April 30, 2027, with two (2) twelve-month option periods.
  • Set-Aside: None (Sole Source)
  • NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing (Size Standard: 1,300 Employees)
  • Capability Statement Due: February 20, 2026, at 10:00 AM Eastern Time (ET)
  • Published: February 5, 2026

Evaluation

This is not a request for competitive quotations or proposals. The Government plans to award based on FAR 6.302-1, "Only one responsible source." Capability statements received will be reviewed solely to determine if a competitive procurement is warranted. The decision not to compete is at the Government's discretion.

Additional Notes

A written justification for the sole-source award will be posted within 14 days after contract award if the dollar amount meets the threshold. Do not include proprietary, classified, confidential, or sensitive information in responses. The Government will not pay for information provided.

People

Points of Contact

LaTerrica SewellContracting OfficerPRIMARY

Files

Files

Download

Versions

Version 1Viewing
Special Notice
Posted: Feb 5, 2026
6525--Intent to Sole Source: TheraSphere Y-90 Glass Microspheres | GovScope